Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Pristanic acid provokes lipid, protein, and DNA oxidative damage and reduces the antioxidant defenses in cerebellum of young rats.

Tytuł:
Pristanic acid provokes lipid, protein, and DNA oxidative damage and reduces the antioxidant defenses in cerebellum of young rats.
Autorzy:
Busanello EN; Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcelos, 2600 - Anexo, Porto Alegre, RS, CEP 90035-003, Brazil.
Lobato VG
Zanatta Â
Borges CG
Tonin AM
Viegas CM
Manfredini V
Ribeiro CA
Vargas CR
de Souza DO
Wajner M
Źródło:
Cerebellum (London, England) [Cerebellum] 2014 Dec; Vol. 13 (6), pp. 751-9.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Publication: <2006->: New York : Springer
Original Publication: London : Martin Dunitz, c2002-
MeSH Terms:
Antioxidants/*metabolism
Cerebellum/*drug effects
Cerebellum/*metabolism
Fatty Acids/*toxicity
Oxidation-Reduction/*drug effects
Aconitate Hydratase/metabolism ; Animals ; Animals, Newborn ; Cells, Cultured ; DNA Damage/drug effects ; Fluoresceins/metabolism ; Glutathione/metabolism ; Homeostasis/drug effects ; Ketoglutarate Dehydrogenase Complex/metabolism ; Malondialdehyde/metabolism ; Melatonin/administration & dosage ; Neurons/drug effects ; Neurons/metabolism ; Neuroprotective Agents/administration & dosage ; Nitric Oxide Synthase/antagonists & inhibitors ; Nitric Oxide Synthase/metabolism ; Rats, Wistar ; Sulfhydryl Compounds/metabolism ; alpha-Tocopherol/pharmacology
References:
Brain Res. 2011 Mar 25;1382:259-65. (PMID: 21241675)
Mutat Res. 2000 Nov 20;455(1-2):81-95. (PMID: 11113469)
Mutat Res. 2008 Jul-Aug;659(1-2):4-14. (PMID: 18083609)
J Lipid Res. 2002 Mar;43(3):438-44. (PMID: 11893780)
Clin Chim Acta. 2003 Mar;329(1-2):23-38. (PMID: 12589963)
Mutat Res. 2010 Sep 30;702(1):123-8. (PMID: 20659584)
Nat Genet. 2000 Feb;24(2):188-91. (PMID: 10655068)
Clin Genet. 2014 Apr;85(4):343-6. (PMID: 23590336)
Free Radic Biol Med. 2011 Sep 1;51(5):1000-13. (PMID: 21664268)
J Biol Chem. 1951 Nov;193(1):265-75. (PMID: 14907713)
J Clin Pathol. 2001 Mar;54(3):176-86. (PMID: 11253127)
J Inherit Metab Dis. 2008 Apr;31(2):270-80. (PMID: 18415699)
J Neurochem. 2014 Jul;130(1):61-74. (PMID: 24673378)
Mol Genet Metab. 2004 Nov;83(3):252-63. (PMID: 15542397)
Neurochem Res. 2005 Oct;30(10):1331-8. (PMID: 16341595)
Mutagenesis. 1995 Nov;10(6):555-9. (PMID: 8596477)
J Neurosci Res. 2012 Mar;90(3):597-605. (PMID: 22183871)
Free Radic Res. 2007 Nov;41(11):1261-72. (PMID: 17987455)
Curr Pharm Des. 2004;10(14):1611-26. (PMID: 15134560)
Am J Clin Nutr. 1995 Dec;62(6 Suppl):1357S-1364S. (PMID: 7495231)
J Neurosci Res. 2008 Feb 15;86(3):683-93. (PMID: 17941049)
Biochem J. 1954 Dec;58(4):685-92. (PMID: 13230022)
Neurochem Res. 2011 Jun;36(6):1101-7. (PMID: 21445584)
Brain Res. 2012 Oct 10;1478:74-82. (PMID: 22967964)
Mutat Res. 1975 Feb;31(1):9-15. (PMID: 48190)
Arch Biochem Biophys. 2001 Apr 15;388(2):261-6. (PMID: 11368163)
Mol Cell Neurosci. 2013 Jul;55:13-6. (PMID: 22820180)
J Histochem Cytochem. 2001 Sep;49(9):1183-6. (PMID: 11511687)
J Biol Chem. 1995 Jun 2;270(22):13399-405. (PMID: 7768942)
Free Radic Biol Med. 2002 May 1;32(9):790-6. (PMID: 11978480)
Methods Enzymol. 1994;233:357-63. (PMID: 8015470)
Ann N Y Acad Sci. 1997 Oct 15;825:70-8. (PMID: 9369975)
Mutat Res. 1999 Jul 16;428(1-2):271-83. (PMID: 10517999)
J Neurochem. 1986 Nov;47(5):1376-86. (PMID: 3760866)
Anal Biochem. 2009 Nov 15;394(2):147-58. (PMID: 19664585)
Mol Genet Metab. 2003 Aug;79(4):281-7. (PMID: 12948743)
Methods Mol Med. 2005;111:3-32. (PMID: 15911968)
Neurosci Lett. 2001 Apr 20;302(2-3):141-5. (PMID: 11290407)
Neuroscience. 2000;101(3):563-70. (PMID: 11113305)
J Cereb Blood Flow Metab. 1987 Dec;7(6):752-8. (PMID: 3693430)
Antioxid Redox Signal. 2006 Nov-Dec;8(11-12):2039-45. (PMID: 17034348)
Neurology. 2013 May 14;80(20):e207-10. (PMID: 23671347)
Methods Enzymol. 2010;474:123-47. (PMID: 20609908)
J Neurochem. 2006 Jun;97(6):1634-58. (PMID: 16805774)
J Pediatr Endocrinol Metab. 2013;26(3-4):377-9. (PMID: 23327810)
Methods Mol Biol. 1998;108:107-10. (PMID: 9921520)
Exp Cell Res. 1988 Mar;175(1):184-91. (PMID: 3345800)
Free Radic Biol Med. 2012 Jan 1;52(1):46-58. (PMID: 22056908)
Exp Biol Med (Maywood). 2007 May;232(5):592-606. (PMID: 17463155)
Antioxid Redox Signal. 2008 May;10(5):891-937. (PMID: 18205545)
J Neurosci. 2004 Sep 8;24(36):7771-8. (PMID: 15356188)
Prog Lipid Res. 2001 Nov;40(6):453-66. (PMID: 11591435)
Methods Mol Biol. 2012;846:23-37. (PMID: 22367798)
Neurobiol Dis. 2009 Nov;36(2):401-10. (PMID: 19703563)
Environ Mol Mutagen. 2000;35(3):206-21. (PMID: 10737956)
Methods Mol Biol. 1998;108:347-52. (PMID: 9921543)
Mutagenesis. 2003 Jan;18(1):45-51. (PMID: 12473734)
Substance Nomenclature:
0 (Antioxidants)
0 (Fatty Acids)
0 (Fluoresceins)
0 (Neuroprotective Agents)
0 (Sulfhydryl Compounds)
4Y8F71G49Q (Malondialdehyde)
56NQM5UZT1 (2',7'-dichlorofluorescein)
5FMQ2908AP (pristanic acid)
EC 1.14.13.39 (Nitric Oxide Synthase)
EC 1.2.4.2 (Ketoglutarate Dehydrogenase Complex)
EC 4.2.1.3 (Aconitate Hydratase)
GAN16C9B8O (Glutathione)
H4N855PNZ1 (alpha-Tocopherol)
JL5DK93RCL (Melatonin)
Entry Date(s):
Date Created: 20140831 Date Completed: 20150717 Latest Revision: 20211021
Update Code:
20240104
DOI:
10.1007/s12311-014-0593-0
PMID:
25172216
Czasopismo naukowe
Zellweger syndrome (ZS) and some peroxisomal diseases are severe inherited disorders mainly characterized by neurological symptoms and cerebellum abnormalities, whose pathogenesis is poorly understood. Biochemically, these diseases are mainly characterized by accumulation of pristanic acid (Prist) and other fatty acids in the brain and other tissues. In this work, we evaluated the in vitro influence of Prist on redox homeostasis by measuring lipid, protein, and DNA damage, as well as the antioxidant defenses and the activities of aconitase and α-ketoglutarate dehydrogenase in cerebellum of 30-day-old rats. The effect of Prist on DNA damage was also evaluated in blood of these animals. Some parameters were also evaluated in cerebellum from neonatal rats and in cerebellum neuronal cultures. Prist significantly increased malondialdehyde (MDA) levels and carbonyl formation and reduced sulfhydryl content and glutathione (GSH) concentrations in cerebellum of young rats. It also caused DNA strand damage in cerebellum and induced a high micronuclei frequency in blood. On the other hand, this fatty acid significantly reduced α-ketoglutarate dehydrogenase and aconitase activities in rat cerebellum. We also verified that Prist-induced increase of MDA levels was totally prevented by melatonin and attenuated by α-tocopherol but not by the nitric oxide synthase inhibitor N(ω)-nitro-L-arginine methyl ester, indicating the involvement of reactive oxygen species in this effect. Cerebellum from neonate rats also showed marked alterations of redox homeostasis, including an increase of MDA levels and a decrease of sulfhydryl content and GSH concentrations elicited by Prist. Finally, Prist provoked an increase of dichlorofluorescein (DCFH) oxidation in cerebellum-cultivated neurons. Our present data indicate that Prist compromises redox homeostasis in rat cerebellum and blood and inhibits critical enzymes of the citric acid cycle that are susceptible to free radical attack. The present findings may contribute to clarify the pathogenesis of the cerebellar alterations observed in patients affected by ZS and some peroxisomal disorders in which Prist is accumulated.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies